In last trading session, Sangamo Therapeutics Inc (NASDAQ:SGMO) saw 11.03 million shares changing hands with its beta currently measuring 1.22. Company’s recent per share price level of $0.58 trading at $0.07 or 13.27% at ring of the bell on the day assigns it a market valuation of $142.82M. That closing price of SGMO’s stock is at a discount of -448.28% from its 52-week high price of $3.18 and is indicating a premium of 48.28% from its 52-week low price of $0.30.
For Sangamo Therapeutics Inc (SGMO), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 1.71. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Sangamo Therapeutics Inc (NASDAQ:SGMO) trade information
Upright in the green during last session for gaining 13.27%, in the last five days SGMO remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $0.58 price level, adding 1.49% to its value on the day. Sangamo Therapeutics Inc’s shares saw a change of 30.85% in year-to-date performance and have moved 20.47% in past 5-day. Sangamo Therapeutics Inc (NASDAQ:SGMO) showed a performance of 22.97% in past 30-days.
Wall Street analysts have assigned a consensus price target of 2.5 to the stock, which implies a rise of 76.8% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 3. It follows that stock’s current price would drop -244.83% in reaching the projected high whereas dropping to the targeted low would mean a loss of -244.83% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 10.57% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 25.18% while estimates for its earnings growth in next 5 years are of 20.67%.
Sangamo Therapeutics Inc (NASDAQ:SGMO)’s Major holders
WASATCH ADVISORS LP is the top institutional holder at SGMO for having 20.09 million shares of worth $7.2 million. And as of 2024-06-30, it was holding 9.8509 of the company’s outstanding shares.
The second largest institutional holder is ARMISTICE CAPITAL, LLC, which was holding about 14.06 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.894 of outstanding shares, having a total worth of $5.04 million.
